LOUIS HACHETTE 1.756 € (+0,06 %)
LIGHTON 6.140 € (-3,31 %)
FDJ UNITED 22.710 € (+2,21 %)
STMICROELECTRONICS 60.230 € (-4,94 %)
SIRIUS MEDIA 0.730 € (+4,26 %)
SAINT GOBAIN 80.460 € (+1,62 %)
TELEPERFORMANCE 51.120 € (+1,03 %)
VALLOUREC 20.490 € (+1,19 %)
BE SEMICONDUCTOR 245.100 € (-5,04 %)
ASM INTERNATIONAL 915.600 € (-5,06 %)
ASML HOLDING 1 544.600 € (-5,15 %)
THALES 244.700 € (+1,49 %)
LVMH 499.100 € (+1,57 %)
CREDIT AGRICOLE 17.910 € (+0,34 %)
AALBERTS NV 39.700 € (-2,02 %)
LEGRAND 144.100 € (+0,77 %)
PERNOD RICARD 65.100 € (+4,23 %)
KERING 256.150 € (+2,58 %)
SOITEC 103.900 € (-12,25 %)
MICHELIN 35.500 € (+1,11 %)
L'OREAL 387.800 € (+2,59 %)
THX PHARMA 3.550 € (-2,47 %)
TF1 6.750 € (-0,59 %)
CA TOULOUSE 31 CCI 130.500 € (-2,07 %)
Vusion 138.300 € (-1,21 %)
MAGNUM 16.472 € (+1,30 %)
AIR LIQUIDE 179.180 € (+0,89 %)
BNP PARIBAS ACT.A 103.300 € (-0,29 %)
PROSUS 38.780 € (+1,64 %)
SCHNEIDER ELECTRIC 273.350 € (-1,80 %)
AXA 44.440 € (+0,61 %)
HAFFNER ENERGY 0.244 € (-2,79 %)
NANOBIOTIX 34.440 € (-2,10 %)
ABN AMRO BANK N.V. 38.660 € (+0,08 %)
EXOR NV 69.950 € (+0,36 %)
SOCIETE GENERALE 77.850 € (+0,12 %)
ING GROEP N.V. 28.695 € (-0,09 %)
OSE IMMUNO 3.422 € (-4,41 %)
ADYEN 870.000 € (+0,16 %)
AIRBUS 208.550 € (-0,41 %)
VINCI 125.300 € (+0,04 %)
LHYFE 1.860 € (0,00 %)
FUGRO 9.355 € (-0,74 %)
JACQUES BOGART 1.835 € (+5,16 %)
SAFRAN 353.800 € (-0,92 %)
HIGH CO 3.650 € (+1,39 %)
EXAIL TECHNOLOGIES 124.400 € (-0,56 %)
VOPAK 46.720 € (+0,21 %)
VICAT 66.500 € (-0,60 %)
GENFIT 13.140 € (-1,94 %)
EXOSENS 59.800 € (-0,25 %)
ABIVAX 124.700 € (-3,26 %)
KPN KON 4.221 € (+1,05 %)
MEDINCELL 28.560 € (+0,28 %)
WOLTERS KLUWER 59.320 € (+2,49 %)
MERSEN 38.680 € (-7,42 %)
X-FAB 8.355 € (-3,63 %)
EDP 4.600 € (+0,46 %)
ENGIE 27.400 € (+0,70 %)
BIOMERIEUX 70.900 € (+1,94 %) |
24/06/2026 18:00
Annual Results 2025-26Paris, 24 June 2026 – EuropaCorp, one of Europe's leading independent film studios, producer and distributor of motion pictures, announces its consolidated annual results, approved by the Board of Directors on June 23, 2026, for the year ended March 31, 2026.1) Annual Results for 2025/2026
Profit & Loss – in millions of euros
Contacts
International Sales generated €11.7 million over the financial year, representing approximately 45% of total revenue, compared with €22.0 million in the previous year. These revenues mainly stem from the final deliveries to international distributors of the film Dracula, albeit at lower levels than in the prior year. Revenues related to the film’s U.S. exploitation - released in February 2026 - will be recognized primarily in the following financial year. This business segment also benefited from significant catalogue royalties, notably from Lucy, Colombiana, Transporter 2 and 3, and Taken 3. The Theatrical Distribution segment recorded no revenue during the year, as Dracula, co-produced with LBP, was distributed in France by SND, compared with €0.2 million in 2024/2025, which related to the theatrical release of Weekend in Taipei. Released in France on 30 July 2025, Dracula achieved more than 650,000 admissions, making it one of the strongest-performing French films of the summer. The film was also released in the United States in February 2026, distributed by Vertical Entertainment, where it generated over $13 million at the box office. These performances further enhance the film’s long-term value within the Group’s catalogue. Video & VOD revenues in France and the United States amounted to €1.1 million, slightly down from €1.2 million in the previous year. They mainly consist of VOD sales in France across various titles, including Lucy and films from the Arthur and Taxi franchises. Television & SVOD revenues in France and the United States more than doubled in FY 2025/2026, reaching €12.1 million, or 46% of total revenue, compared with €5.2 million in the prior year. Primarily driven by the French market, these revenues benefited from the opening of broadcasting windows for several catalogue titles, notably the Taxi and Transporter franchises, as well as Lucy and Bis. Series revenue amounted to €0.1 million in FY 2025/2026, compared with €0.8 million in the prior year. This revenue mainly relates to royalties from the Taken series, released more than nine years ago. Revenue from Other Activities totalled €1.2 million, compared with €2.2 million in the previous year. This segment includes revenues from ancillary rights (partnerships, licensing, music publishing, private copying, etc.) and co-productions entered into by the Group. The decrease is mainly attributable to lower co-production revenues and private copying levies. Contacts included higher amortization charges related to recent titles within the film slate, notably Dracula and Weekend in Taipei. Depreciation and amortization decreased significantly to €10.0 million in FY 2025/2026, compared with €21.4 million in FY 2024/2025. The prior-year amount mainly reflected the capitalization of Dracula and the commencement of its amortization. Overhead expenses remained under control at €8.5 million, increasing by only 1% year-on-year, reflecting the effectiveness of the Group's cost-reduction measures. Other operating income and expenses amounted to (€0.6) million (compared with €0.6 million in the prior year), and included restructuring costs. As a result, operating income amounted to (€0.3) million, compared with (€3.4) million in the previous fiscal year. Financial result amounted to (€1.6) million, compared with (€1.4) million in FY 2024/2025. It primarily comprised an unfavorable foreign exchange impact of (€1.8) million related to the revaluation of U.S. dollar-denominated bank accounts, €0.8 million of interest income on deposits, and a financial expense of (€0.4) million arising from the application of IFRS 16 to lease agreements. Current income before income tax amounted to (€1.9) million. After recognizing an income tax expense of (€0.1) million, net loss was reduced to (€2.0) million, compared with (€4.9) million in the previous fiscal year.
Net cash flows from operating activities amounted to €12.0 million, compared with €20.6 million in the previous fiscal year. This €8.5 million decrease mainly reflects lower cash inflows from international sales. Net cash flows from investing activities amounted to (€17.3) million, compared with (€20.7) million for the year ended 31 March 2025. They mainly relate to investments in intangible assets as of 31 March 2026, notably the films Father Joe and Dracula. Net cash flows from financing activities amounted to (€13.8) million, compared with (€6.1) million a year earlier. This includes the payment of the fifth instalment of the Safeguard Plan, comprising €10.6 million of principal repayment on Senior debt (compared with €5.8 million in 2024/2025). Contacts
At 31 March 2026, net debt amounted to €33.9 million, compared with €27.6 million at 31 March 2025. OutlookEuropaCorp continues to pursue its growth strategy based on three complementary pillars: the monetization of its catalogue of iconic franchises, the development of high international potential productions, and the structuring of strategic European co-productions. The Group produced or co-produced several films during the fiscal year, including upcoming releases in the next fiscal year such as Father Joe. Father JoeWritten by Luc Besson and directed by Barthélemy Grossmann, Father Joe stars Kiefer Sutherland and Al Pacino in a thriller set in 1990s New York. A priest with a military past wages a secret war against the local mafia. From a church turned fortress, he enforces his own brutal form of justice, between faith, violence and redemption. Currently in post-production, the film is produced by LBP in co-production with EuropaCorp. Active development pipelineIn parallel, leveraging its catalogue and long-standing expertise in internationally oriented productions, the Group continues to develop ambitious projects aligned with evolving market trends. EuropaCorp is actively developing around fifteen film and series projects, in both French and English, intended for theatrical release and streaming platforms, some of which involve collaborations with internationally recognized talent and partners. The Group continues to focus its strategy on its core genres: action, thriller and comedy. ABOUT EUROPACORPFounded in 1999, EuropaCorp has become one of Europe's leading film and series production studios. The Group's international activities cover the entire cinematographic value chain, with expertise in production, theatrical distribution, international sales, TV, video & VOD, and music publishing. EuropaCorp is able to ensure creativity and quality throughout the life cycle of its films and TV projects. The Group has produced or co-produced over 120 films and distributed over 160 to French cinemas. Since 1999, it has produced 10 of France's 20 biggest international hits and 22 films among the 70 French productions with the most international admissions (source Le film français - May 17, 2019). Since 2010, the Group has also been active in the production of TV unitaries and series for platforms worldwide. EuropaCorp was founded by director, screenwriter and producer Luc Besson. More information at www.europacorp.com Contacts Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière